Eric Venker's Planned Sale of Roivant Sciences Ltd. Common Shares

Eric Venker, an officer of Roivant Sciences Ltd., has filed a Form 144 to sell 414,683 common shares of the company. The shares will be sold pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. The shares were acquired on October 15, 2025, through the exercise of options granted on March 26, 2020. The aggregate market value of the shares to be sold is approximately $7,021,429.14. Additionally, Venker has engaged in multiple transactions over the past three months, selling a total of 2,687,644 common shares for gross proceeds exceeding $37 million. The sales were executed through Rockefeller Financial LLC, with the most recent transaction occurring on October 13, 2025.